• Publications
  • Influence
The response of metastatic adenocarcinoma of the prostate to exogenous testosterone.
In a retrospective review the response of 67 patient with metastatic adenocarcinoma of the prostate to the administration of exogenous testosterone was analyzed. Among 52 patients in whom objectiveExpand
  • 229
  • 9
Intravesical bacillus Calmette-Guérin therapy prevents tumor progression and death from superficial bladder cancer: ten-year follow-up of a prospective randomized trial.
PURPOSE Superficial bladder tumors (stage Ta, T1, and Tis) may progress to invade the bladder muscle and cause death from metastatic cancer. Transurethral tumor resection (TURB) is the standardExpand
  • 270
  • 7
Cell surface antigens of human bladder cancer defined by mouse monoclonal antibodies.
Mouse monoclonal antibodies were obtained by immunization with cultured human bladder cancer or lysates of bladder papilloma. They identify 11 distinct antigenic systems as defined by serologicalExpand
  • 254
  • 6
  • PDF
Epidemiology of cancer of the prostate
This study of the epidemiology of cancer of the prostate was based on a retrospective investigation of 300 patients with cancer of the prostate and 400 controls, a review of the charts of anExpand
  • 283
  • 5
Intermittent endocrine therapy for advanced prostate cancer
Twenty patients with advanced prostate cancer have been treated with an intermittent endocrine therapy schedule. Hormone therapy (diethylstilbestrol in 19 patients and flutamide in 1 patient) wasExpand
  • 160
  • 5
Penile cancer: relation of extent of nodal metastasis to survival.
A retrospective review of 199 patients with penile cancer revealed that the extent of inguinal nodal metastasis was related to survival after radical ilioinguinal dissection. Patients with unilateralExpand
  • 213
  • 4
Effects of combined drug therapy on metastatic cancer of the testis.
Advanced cancer of the testis was treated in 36 patients with different combinations of an alkylating agent, an antimetabolite, and the antitumor antibiotic actinomycin D. Of 23 patients treated withExpand
  • 339
  • 3
Radical total cystectomy for cancer of the bladder:230 consecutive cases five years later.
  • 237
  • 3
Bacillus Calmette-Guérin therapy alters the progression of superficial bladder cancer.
The effectiveness of BCG in preventing disease progression in patients with superficial bladder cancer is evaluated. Long-term follow-up of high-risk patients treated in a previously reportedExpand
  • 250
  • 3
Superficial bladder cancer treated with bacillus Calmette-Guerin: a multivariate analysis of factors affecting tumor progression.
A multivariate analysis was performed on data from 221 patients with superficial bladder tumors (papilloma in 30, grade II to III stage Ta in 51, grade II to III stage Tis in 111 and grade II to IIIExpand
  • 218
  • 3